文献

J-GLOBAL ID：201602228746203093   整理番号：16A0691627

治癒切除後のborderline resectable膵管腺癌の患者における術前の独立予後因子:好中球-リンパ球比および血小板-リンパ球比

Preoperative independent prognostic factors in patients with borderline resectable pancreatic ductal adenocarcinoma following curative resection: the neutrophil-lymphocyte and platelet-lymphocyte ratios

著者 (9件)： Asari Sadaki (Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, Kobe University Graduate School of Medicine, Kobe, Japan) ,  Matsumoto Ippei (Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, Kobe University Graduate School of Medicine, Kobe, Japan) ,  Toyama Hirochika (Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, Kobe University Graduate School of Medicine, Kobe, Japan) ,  Shinzeki Makoto (Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, Kobe University Graduate School of Medicine, Kobe, Japan) ,  Goto Tadahiro (Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, Kobe University Graduate School of Medicine, Kobe, Japan) ,  Ishida Jun (Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, Kobe University Graduate School of Medicine, Kobe, Japan) ,  Ajiki Tetsuo (Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, Kobe University Graduate School of Medicine, Kobe, Japan) ,  Fukumoto Takumi (Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, Kobe University Graduate School of Medicine, Kobe, Japan) ,  Ku Yonson (Division of Hepato-Biliary-Pancreatic Surgery, Department of Surgery, Kobe University Graduate School of Medicine, Kobe, Japan)
資料名： Surgery Today  (Surgery Today)
巻： 46  号： 5  ページ： 583-592  発行年： 2016年05月 
JST資料番号： Z0754A  ISSN： 0941-1291  CODEN： SUTOE5  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： ドイツ (DEU)  言語： 英語 (EN)

抄録/ポイント： 目的:borderline resectable膵管腺癌(B...

シソーラス用語： ヒト ,...
準シソーラス用語： 血小板-リンパ球比 ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=16A0691627&from=J-GLOBAL&jstjournalNo=Z0754A") }}

著者キーワード (5件)： Pancreatic ductal adenocarcinoma ,  Borderline resectable pancreatic ductal adenocarcinoma ,  Prognostic factor ,  Neutrophil-lymphocyte ratio ,  Platelet-lymphocyte ratio

分類 (2件)： 消化器の腫よう  (GH04000D) ,  腫ようの外科療法  (GE03033T)

引用文献 (44件)：

• Neoptolemos JP, Stocken DD, Dunn JA, Almond J, Beger HG, Pederzoli P, et al. Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg. 2001;234:758-68.
• Varadhachary GR, Tamm EP, Abbruzzese JL, Xiong HQ, Crane CH, Wang H, et al. Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy. Ann Surg Oncol. 2006;13:1035-46.
• Katz MH, Pisters PW, Evans DB, Sun CC, Lee JE, Fleming JB, et al. Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. J Am Coll Surg. 2008;206:833-46.
• Callery MP, Chang KJ, Fishman EK, Talamonti MS. William Traverso L, Linehan DC. Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement. Ann Surg Oncol. 2009;16:1727-33.
• Tempero MA, Arnoletti JP, Behrman SW, Ben-Josef E, Benson AB 3rd, Casper ES, et al. Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw. 2012;10:703-13.

タイトルに関連する用語 (8件)： 治癒切除 ,  膵管腺癌 ,  患者 ,  術前 ,  予後因子 ,  好中球 ,  リンパ球 ,  血小板